vancomycin has been researched along with paromomycin in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dabour, N; Fliss, I; Kheadr, E; Lacroix, C; Le Lay, C | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| De Rossi, P; Isaacson, P; Lightbown, JW | 1 |
| Beck, D; Siegenthaler, G; Siegenthaler, W; Weidmann, P | 1 |
| Bodey, GP; Rosenbaum, B | 1 |
| Enari, H | 1 |
| HEJZLAR, M; JELINEK, J; VYMOLA, F | 1 |
| MARTIN, WJ | 1 |
| Auner, HW; Buzina, W; Krause, R; Ofner-Kopeinig, P; Olschewski, H; Paulitsch, A; Reisinger, EC; Staber, PB; Zollner-Schwetz, I | 1 |
| Kohno, S; Morinaga, Y; Nagaoka, K; Yanagihara, K | 1 |
3 review(s) available for vancomycin and paromomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Some proposals for anaerobic primary culture from the supply side].
Topics: Agar; Bacteriological Techniques; Bacteroides fragilis; beta-Lactamases; Culture Media; Humans; Paromomycin; Vancomycin | 2001 |
NEWER ANTIMICROBIAL AGENTS HAVING CURRENT OR POTENTIAL CLINICAL APPLICATION.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Cephalothin; Colistin; Cycloserine; Demeclocycline; Erythromycin; Gentamicins; Griseofulvin; Humans; Kanamycin; Methicillin; Novobiocin; Oxacillin; Paromomycin; Penicillin V; Penicillins; Pharmacology; Ristocetin; Staphylococcal Infections; Toxicology; Troleandomycin; Vancomycin | 1964 |
9 other study(ies) available for vancomycin and paromomycin
| Article | Year |
|---|---|
Antibiotic susceptibility profile of bifidobacteria as affected by oxgall, acid, and hydrogen peroxide stress.
Topics: Acids; Ampicillin; Anti-Bacterial Agents; Bifidobacterium; Chloramphenicol; Cloxacillin; Culture Media; Drug Resistance, Bacterial; Erythromycin; Hydrogen Peroxide; Microbial Sensitivity Tests; Nisin; Penicillins; Species Specificity; Tetracyclines; Vancomycin | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
International standards and international reference preparations: amphotericin B, vancomycin, capreomycin, cefalotin, demethylchlortetracycline, gentamycin, gramicidin S, kanamycin and kanamycin B, lincomycin, lymecycline, methacycline, paromomycin, rifam
Topics: Amphotericin B; Anti-Bacterial Agents; Antitubercular Agents; Capreomycin; Cephalothin; Demeclocycline; Gentamicins; International Cooperation; Kanamycin; Leucomycins; Lincomycin; Lymecycline; Methacycline; Paromomycin; Rifamycins; Ristocetin; Troleandomycin; Tyrothricin; Vancomycin; World Health Organization | 1972 |
[New antibiotics, with the exception of penicillins, streptomycin, tetracyclines and chloramphenicol].
Topics: Anti-Bacterial Agents; Cephalosporins; Chemistry, Pharmaceutical; Erythromycin; Fusidic Acid; Gentamicins; Kanamycin; Leucomycins; Lincomycin; Neomycin; Novobiocin; Oleandomycin; Paromomycin; Polymyxins; Rifampin; Ristocetin; Spectinomycin; Vancomycin; Virginiamycin | 1968 |
Effect of prophylactic measures on the microbial flora of patients in protected environment units.
Topics: Adolescent; Adult; Air Movements; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacterial Infections; Bacteriuria; Child; Ear; Feces; Female; Gentamicins; Humans; Male; Middle Aged; Mycoses; Nose; Nystatin; Paromomycin; Patient Isolators; Pharynx; Polymyxins; Skin; Vagina; Vancomycin | 1974 |
[RAPID DETERMINATION OF THE SENSITIVITY OF BACTERIA TO ANTIBIOTICS].
Topics: Ampicillin; Anti-Bacterial Agents; Chloramphenicol; Colistin; Drug Resistance; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Kanamycin; Methicillin; Neomycin; Oleandomycin; Oxacillin; Paromomycin; Penicillin G; Polymyxins; Research; Rifamycins; Staphylococcus; Streptomycin; Tetracycline; Tetrazolium Salts; Vancomycin | 1963 |
Oral and intestinal Candida colonization in patients undergoing hematopoietic stem-cell transplantation.
Topics: Adult; Aged; Anti-Bacterial Agents; Candida albicans; Candidiasis; Carrier State; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Intestines; Male; Middle Aged; Mouth; Paromomycin; Prevalence; Risk Factors; Vancomycin | 2008 |
Detection of Fusobacterium nucleatum in two cases of empyema and lung abscess using paromomycin-vancomycin supplemented Brucella HK agar.
Topics: Agar; Anti-Bacterial Agents; Bacteriological Techniques; Brucella; Culture Media; Empyema; Fusobacterium Infections; Fusobacterium nucleatum; Humans; Lung Abscess; Male; Middle Aged; Paromomycin; Sequence Analysis, DNA; Vancomycin | 2017 |